NM_007175.8(ERLIN2):c.395C>T (p.Thr132Met) AND not provided
- Germline classification:
- Uncertain significance (1 submission)
- Last evaluated:
- May 1, 2016
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV000999024.22
Allele description [Variation Report for NM_007175.8(ERLIN2):c.395C>T (p.Thr132Met)]
NM_007175.8(ERLIN2):c.395C>T (p.Thr132Met)
Condition(s)
- Synonyms:
- none provided
- Identifiers:
- MedGen: C3661900
-
hypothetical protein, partial [Homo sapiens]
hypothetical protein, partial [Homo sapiens]gi|52545714|emb|CAH56231.1|Protein
-
unnamed protein product [Homo sapiens]
unnamed protein product [Homo sapiens]gi|194373975|dbj|BAG62300.1|Protein
-
Rattus norvegicus transmembrane protein 214 (Tmem214), mRNA
Rattus norvegicus transmembrane protein 214 (Tmem214), mRNAgi|122427847|ref|NM_001014195.2|Nucleotide
-
RecName: Full=Cathelicidin antimicrobial peptide; Contains: RecName: Full=Antiba...
RecName: Full=Cathelicidin antimicrobial peptide; Contains: RecName: Full=Antibacterial peptide FALL-39; AltName: Full=FALL-39 peptide antibiotic; Contains: RecName: Full=Antibacterial peptide LL-37; Flags: Precursorgi|115503708|sp|Q1KLY2.1|CAMP_NOMGAProtein
-
Viloxazine
ViloxazineA morpholine derivative used as an antidepressant. It is similar in action to IMIPRAMINE.<br/>Year introduced: 1991(1977)MeSH
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Oct 20, 2024